Protecting Blood Supplies

  • Wei GuoEmail author
  • Li Li
  • Cynthia X. Shi
  • Nanci Zhang


Blood donation is an effective way for the public to directly contribute to saving lives, and its safety is an essential component of public health. In central China in the 1990s, the failure to ensure basic safeguards in the commercial blood donation process had devastating consequences for the HIV/AIDS epidemic that still reverberate today. An estimated 55,000 people were infected with HIV through unsafe blood donation. The outbreak systematically destroyed family, social, and economic structures, and over two decades later, the death toll is still rising. The advent of blood commerce in Henan province and the subsequent catastrophic HIV outbreak were unsurprisingly precipitated by various economic, governmental, and socio-behavioral factors. After the outbreak was discovered, an extensive HIV screening campaign was conducted, followed by ongoing surveillance among blood donors. It is important in the examination of the disaster to acknowledge contributing forces which gave rise to one of China’s most severe HIV outbreaks, which continues to shape the landscape of blood donation and blood supplies in China today.


  1. Bharmal R, Tiwari R. HIV and AIDS: basic elements and priorities. Berlin: Springer; 2007.Google Scholar
  2. Blattner WA, Biggar RJ, Weiss SH, Melbye M, Goedert JJ. Epidemiology of human T-lymphotropic virus type III and the risk of the acquired immunodeficiency syndrome. Ann Intern Med. 1985;103(5):665–70.CrossRefGoogle Scholar
  3. Chaddah A, Wu Z. Selling blood spreads HIV. In: Wu Z, editor. HIV/AIDS in China—beyond the numbers. Singapore: People’s Medical Publishing House; 2017. p. 9–22.CrossRefGoogle Scholar
  4. Chen C, Zheng X, Liu K, Kang L, Hao R. HIV/AIDS epidemic in China and future trends. In: State Council Research Office, editor. Beware of AIDS: for the survival of the Chinese nation. Beijing: Xinhua Publishing House; 1993. p. 35–58.Google Scholar
  5. Chen SL, Zhang X, Chen ZZ, Wang WJ, Li YL, Li CY, Chen ZL. Mutual blood donation is safer at small blood collection stations in China. Transfus Apher Sci. 2015;53(3):315–9.CrossRefGoogle Scholar
  6. Chen S, Zhao H, Zhang Y, Zhao C. Review of the HIV cross-infection event caused by plasmapheresis in Hebei province. Chin J AIDS STD. 2018;24(2):112–6.Google Scholar
  7. Cui ZL, Wang Z, Liu GH. An analysis of epidemic and trend of HIV/AIDS in Henan Province. Chin J AIDS STD. 2006;12(4):324–6.Google Scholar
  8. Darby SC, Ewart DW, Giangrande IPLF, Spooner RJD, Rizza CR. Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. Lancet. 1996;347(9015):1573–9. Scholar
  9. Erwin K. The circulatory system: blood procurement, AIDS, and the social body in China. Med Anthropol Q. 2006;20(2):139–59.CrossRefGoogle Scholar
  10. Fishbein M. Blood banks, The new illustrated medical and health encyclopedia 1 (Home Library Edition). New York, NY: H.S. Stuttman Co.; 1976.Google Scholar
  11. He M, Wang J, Chen L, Liu J, Zeng P. The impact of emerging infectious diseases on chinese blood safety. Transfus Med Rev. 2017;31(2):94–101. Scholar
  12. Hess JR, Schmidt PJ. The first blood banker: Oswald Hope Robertson. Transfusion. 2000;40(1):110–3. Scholar
  13. Hong Y, Huang X, Ling H, Liao H. Prevalence and trend of HIV infection among voluntary blood donors in China since implementation of the Blood Donation Law: a systematic review and meta-analysis. Tropical Med Int Health. 2012;17(8):978–88. Scholar
  14. Keshavjee S, Weiser S, Kleinman A. Medicine betrayed: hemophilia patients and HIV in the US. Soc Sci Med. 2001;53(8):1081–94. Scholar
  15. Li L, Li KY, Yan K, Ou G, Li W, Wang J, Song N, Tian L, Ji X, Chen Y, Liang X, Liu Z, Wu Y. The history and challenges of blood donor screening in China. Transfus Med Rev. 2017a;31(2):89–93. Scholar
  16. Li T, Wang W, Zhang L, Zhou Y, Lai F, Fu Y, Wang C, Yang B, Zhu W, Wu Y. Designing and implementing a 5-year transfusion medicine diploma program in China. Transfus Med Rev. 2017b;31(2):126–31.CrossRefGoogle Scholar
  17. Ministry of Health of People’s Republic of China, Joint United Nations Programme on HIV/AIDS, World Health Organization. 2005 Update on the HIV/AIDS Epidemic and Response in China. 2006.
  18. Nakasone T, Hara T, Yoshino N, Honda M. Update on HIV/AIDS in Japan, 2003. In: Lu Y, Essex M, Stiefvater E, editors. AIDS in Asia. Boston, MA: Springer; 2004. p. 73–81.CrossRefGoogle Scholar
  19. National Center for AIDS/STD Control and Prevention/China CDC. 2017 National HIV/STD/HCV Program Implementation Report. Beijing: National Center for AIDS/STD Control and Prevention/China CDC; 2018.Google Scholar
  20. Rosenthal E. Blood and tears: a Chinese family’s ordeal in a nation in denial of AIDS. 2001. Accessed 31 Oct 2001.
  21. Shi L, Wang J, Liu Z, Stevens L, Sadler A, Ness P, Shan H. Blood donor management in china. Transfus Med Hemother. 2014a;41(4):273–82. Scholar
  22. Shi L, Wang JX, Stevens L, Ness P, Shan H. Blood safety and availability: continuing challenges in China’s blood banking system. Transfusion. 2014b;54(2):471–82. Scholar
  23. Slavov SN, Kashima S, Pinto ACS, Covas DT. Human parvovirus B19: general considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions. FEMS Immunol Med Microbiol. 2011;62(3):247–62. Scholar
  24. Sun T, Lu SF, Jin GZ. Solving shortage in a priceless market: insights from blood donation. J Health Econ. 2016;48:149–65.CrossRefGoogle Scholar
  25. Wang P, Zeng Y, Tsuchie H, Kurimura T, Hinuma Y. Detection of HTVL-III antibody by immune-fluorescence test in China. Chin J Virol. 1985;1(4):391–2.Google Scholar
  26. World Health Organization. Utilization and supply of human blood products. World Health Organization Resolution 28.72, Geneva, Switzerland, Presented at the 28th World Health Assembly; 1975.Google Scholar
  27. World Health Organization. 2, Voluntary blood donation: foundation of a safe and sufficient blood supply. In: Towards 100% voluntary blood donation: a global framework for action. Geneva: World Health Organization; 2010.Google Scholar
  28. World Health Organization. The 2016 global status report on blood safety and availability. Geneva: World Health Organization; 2017.Google Scholar
  29. Wu Z, Liu Z, Detels R. HIV-1 infection in commercial plasma donors in China. Lancet. 1995;346(8966):61–2. Scholar
  30. Wu Z, Rou K, Detels R. Prevalence of HIV infection among former commercial plasma donors in rural eastern China. Health Policy Plan. 2001;16(1):41–6.CrossRefGoogle Scholar
  31. Xu J, Han X, Reilly KH, Shang H. New features of the HIV epidemic among men who have sex with men in China. Emerg Microbes Infect. 2013;2:e45. Scholar
  32. Yan J, Zheng X, Zhang X, Liu S, Zhang Y, Wang C, Liu S. The survey of prevalence of HIV infection among paid blood donors in one county in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2000;21(1):10–3.PubMedGoogle Scholar
  33. Ye X, Yang B, Zhu W, Zheng X, Du P, Zeng J, Li C. Six-year pilot study on nucleic acid testing for blood donations in China. Transfus Apher Sci. 2013;49(2):318–22. Scholar
  34. Yin YH, Li CQ, Liu Z. Blood donation in China: sustaining efforts and challenges in achieving safety and availability. Transfusion. 2015;55(10):2523–30.CrossRefGoogle Scholar
  35. Yu X, Chen W, Liu Z, Huang Y. Safety and current status of blood transfusion in China: an update. Lancet Haematol. 2016;3(2):e60–2. Scholar
  36. Zeng Y, Fan J, Zhang Q, Wang PC, Tang DJ, Zhon SC, Zheng XW, Liu DP. Detection of antibody to LAV/HTLV-III in sera from hemophiliacs in China. AIDS Res. 1986;2(Suppl 1):S147–9.Google Scholar
  37. Zhu Y, Xie D, Wang X, Qian K. Challenges and research in managing blood supply in China. Transfus Med Rev. 2017;31(2):84–8. Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  1. 1.NCAIDSChina CDCBeijingChina
  2. 2.Yale School of Public HealthNew HavenUSA

Personalised recommendations